封面
市場調查報告書
商品編碼
1618181

眼科縫合線市場機會、成長促進因素、產業趨勢分析及 2024 年至 2032 年預測

Ophthalmic Sutures Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2024 to 2032

出版日期: | 出版商: Global Market Insights Inc. | 英文 130 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2023 年,全球眼科縫合線市場價值為 9.063 億美元,預計 2024-2032 年複合年成長率為 6.2%。這種成長主要是由於眼部疾病的盛行率不斷上升,特別是在老年人口中,以及白內障、青光眼和糖尿病視網膜病變等疾病發生率的上升。因此,眼科手術的需求不斷增加,進一步推動市場擴張。市場分為兩大類:天然縫合線和合成縫合線。 2023 年,合成材料領域成為領先者,收入達 6.205 億美元。

合成縫合線是在嚴格的條件下生產的,可確保一致性和可靠性,這使得它們對於精確度至關重要的複雜眼科手術至關重要。聚丙烯、尼龍和聚乙醇酸等材料具有優異的拉伸強度、彈性和生物相容性,對於維持傷口完整性和促進敏感眼組織的癒合至關重要。這些功能的組合促進了市場對合成選項不斷成長的需求。從塗層類型來看,眼科縫線可分為塗層和無塗層兩類。

無塗層縫線預計將實現可觀的收入,預計到2032 年將達到約11 億美元。是眼科手術中的關鍵因素,在眼科手術中,安全結是必要的保持組織接近並防止滑動。此外,無塗層縫線不含其他物質,可最大限度地降低發炎反應的風險,這在處理脆弱的眼組織時尤其重要。 2023年北美眼科縫合線市場收入為3.535億美元,預計未來幾年將大幅成長。北美地區,尤其是人口老化地區,與年齡相關的眼部疾病數量不斷增加,正在推動眼科手術的需求。人口趨勢和強大的醫療基礎設施相結合,使北美成為眼科縫合線市場的關鍵參與者,為擴張和創新提供了充足的機會。

市場範圍
開始年份 2023年
預測年份 2024-2032
起始值 9.063 億美元
預測值 16 億美元
複合年成長率 6.2%

目錄

第 1 章:方法與範圍

第 2 章:執行摘要

第 3 章:產業洞察

  • 產業生態系統分析
  • 產業影響力
    • 成長動力
      • 眼部疾病盛行率不斷上升
      • 技術進步
      • 糖尿病盛行率上升導致眼科疾病
      • 有利的政府舉措
      • 對微創手術的需求和偏好激增
    • 產業陷阱與挑戰
      • 與眼科手術相關的術後併發症
      • 缺乏熟練的眼科醫生
  • 成長潛力分析
  • 技術景觀
  • 未來市場趨勢
  • 監管環境
  • 報銷場景
  • 按類型定價分析
  • 差距分析
  • 波特的分析
  • PESTEL分析

第 4 章:競爭格局

  • 介紹
  • 公司矩陣分析
  • 主要市場參與者的競爭分析
  • 公司市佔率分析
  • 競爭定位矩陣
  • 戰略儀表板

第 5 章:市場估計與預測:按類型,2021 - 2032

  • 主要趨勢
  • 自然的
  • 合成的

第 6 章:市場估計與預測:按材料分類,2021 - 2032 年

  • 主要趨勢
  • 職業高爾夫球協會
  • 尼龍
  • 絲綢
  • 聚丙烯
  • 其他材料

第 7 章:市場估計與預測:按塗料分類,2021 - 2032 年

  • 主要趨勢
  • 塗層
  • 無塗層

第 8 章:市場估計與預測:按材料結構,2021 - 2032

  • 主要趨勢
  • 單絲
  • 複絲/編織

第 9 章:市場估計與預測:按吸收率分類,2021 - 2032 年

  • 主要趨勢
  • 可吸收
  • 不可吸收

第 10 章:市場估計與預測:按應用分類,2021 - 2032

  • 主要趨勢
  • 白內障手術
  • 角膜移植手術
  • 青光眼手術
  • 玻璃體切除術
  • 眼部整形手術
  • 其他應用

第 11 章:市場估計與預測:按最終用途,2021 - 2032 年

  • 主要趨勢
  • 醫院
  • 門診手術中心
  • 其他最終用戶

第 12 章:市場估計與預測:按地區分類,2021 - 2032 年

  • 主要趨勢
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東和非洲
    • 沙烏地阿拉伯
    • 南非
    • 阿拉伯聯合大公國

第 13 章:公司簡介

  • Alcon
  • Assut Medical
  • Aurolab
  • Accutome
  • B Braun Melsungen AG
  • Corzamedical
  • DemeTECH Corporation.
  • Ethicon (J&J)
  • FCI Ophthalmics
  • Geuder AG
  • Mani
  • Medtronic
  • Teleflex Incorporated
  • Unilene
簡介目錄
Product Code: 3358

The Global Ophthalmic Sutures Market was worth USD 906.3 million in 2023 and is projected to grow at a 6.2% CAGR throughout 2024-2032. This growth is largely fueled by the increasing prevalence of eye disorders, particularly among the aging population, as well as the rising incidence of conditions such as cataracts, glaucoma, and diabetic retinopathy. Consequently, the demand for ophthalmic surgeries is on the rise, further propelling market expansion. The market is divided into two main categories: natural and synthetic sutures. In 2023, the synthetic segment emerged as the leader, generating revenue of USD 620.5 million.

Synthetic sutures are produced under stringent conditions that ensure consistency and reliability, making them essential for intricate ophthalmic procedures where precision is critical. Materials such as polypropylene, nylon, and polyglycolic acid exhibit excellent tensile strength, elasticity, and biocompatibility vital for maintaining wound integrity and promoting healing in sensitive eye tissues. This combination of features contributes to the growing demand for synthetic options in the market. Regarding coating types, ophthalmic sutures can be classified into coated and uncoated categories.

The uncoated segment is anticipated to achieve significant revenue, projected to reach around USD 1.1 billion by 2032. Uncoated sutures generally possess a higher friction coefficient than their coated counterparts, which enhances knot security-a crucial factor in ophthalmic procedures where secure knots are necessary to maintain tissue approximation and prevent slippage. Furthermore, the absence of additional substances in uncoated sutures minimizes the risk of inflammatory reactions, which is especially important when dealing with delicate eye tissues. The North American ophthalmic sutures market accounted for USD 353.5 million in revenue in 2023 and is expected to experience considerable growth in the coming years. The increasing number of age-related eye disorders in North America, particularly in regions with aging populations, is driving demand for ophthalmic procedures.Additionally, advanced healthcare facilities that can handle complex surgeries play a significant role in the market's growth. The combination of demographic trends and robust healthcare infrastructure positions North America as a key player in the ophthalmic sutures market, providing ample opportunities for expansion and innovation.

Market Scope
Start Year2023
Forecast Year2024-2032
Start Value$906.3 Million
Forecast Value$1.6 Billion
CAGR6.2%

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definition
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates & calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Growing prevalence of eye diseases
      • 3.2.1.2 Technological advancements
      • 3.2.1.3 Rising prevalence of diabetes leading to ophthalmic disorders
      • 3.2.1.4 Favorable government initiatives
      • 3.2.1.5 Surging demand and preference for minimally invasive surgeries
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 Postoperative complications associated with ophthalmic procedures
      • 3.2.2.2 Lack of skilled ophthalmologist
  • 3.3 Growth potential analysis
  • 3.4 Technology landscape
  • 3.5 Future market trends
  • 3.6 Regulatory landscape
  • 3.7 Reimbursement scenario
  • 3.8 Pricing analysis, by type
  • 3.9 Gap analysis
  • 3.10 Porter's analysis
  • 3.11 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Competitive analysis of major market players
  • 4.4 Company market share analysis
  • 4.5 Competitive positioning matrix
  • 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Type, 2021 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Natural
  • 5.3 Synthetic

Chapter 6 Market Estimates and Forecast, By Material, 2021 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 PGA
  • 6.3 Nylon
  • 6.4 Silk
  • 6.5 Polypropylene
  • 6.6 Other materials

Chapter 7 Market Estimates and Forecast, By Coating, 2021 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 Coated
  • 7.3 Uncoated

Chapter 8 Market Estimates and Forecast, By Material Structure, 2021 - 2032 ($ Mn)

  • 8.1 Key trends
  • 8.2 Monofilament
  • 8.3 Multifilament/braided

Chapter 9 Market Estimates and Forecast, By Absorption, 2021 - 2032 ($ Mn)

  • 9.1 Key trends
  • 9.2 Absorbable
  • 9.3 Non-absorbable

Chapter 10 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

  • 10.1 Key trends
  • 10.2 Cataract surgery
  • 10.3 Corneal transplantation surgery
  • 10.4 Glaucoma surgery
  • 10.5 Vitrectomy
  • 10.6 Oculoplastic surgery
  • 10.7 Other applications

Chapter 11 Market Estimates and Forecast, By End Use, 2021 - 2032 ($ Mn)

  • 11.1 Key trends
  • 11.2 Hospitals
  • 11.3 Ambulatory surgical centers
  • 11.4 Other end users

Chapter 12 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

  • 12.1 Key trends
  • 12.2 North America
    • 12.2.1 U.S.
    • 12.2.2 Canada
  • 12.3 Europe
    • 12.3.1 Germany
    • 12.3.2 UK
    • 12.3.3 France
    • 12.3.4 Italy
    • 12.3.5 Spain
    • 12.3.6 Netherlands
  • 12.4 Asia Pacific
    • 12.4.1 China
    • 12.4.2 Japan
    • 12.4.3 India
    • 12.4.4 Australia
    • 12.4.5 South Korea
  • 12.5 Latin America
    • 12.5.1 Brazil
    • 12.5.2 Mexico
    • 12.5.3 Argentina
  • 12.6 Middle East and Africa
    • 12.6.1 Saudi Arabia
    • 12.6.2 South Africa
    • 12.6.3 UAE

Chapter 13 Company Profiles

  • 13.1 Alcon
  • 13.2 Assut Medical
  • 13.3 Aurolab
  • 13.4 Accutome
  • 13.5 B Braun Melsungen AG
  • 13.6 Corzamedical
  • 13.7 DemeTECH Corporation.
  • 13.8 Ethicon (J&J)
  • 13.9 FCI Ophthalmics
  • 13.10 Geuder AG
  • 13.11 Mani
  • 13.12 Medtronic
  • 13.13 Teleflex Incorporated
  • 13.14 Unilene